| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jan 06, 2025 | Jan 06, 2025 | Slonin Jonathan Chief Medical Officer | Sell | Pacira Biosciences, Inc. | PCRX | $18.4 | $16,174 | -0.93% |
| Aug 02, 2024 | Aug 02, 2024 | Slonin Jonathan Chief Medical Officer | Sell | Pacira Biosciences, Inc. | PCRX | $20.05 | $18,947 | -0.99% |
| Jul 02, 2024 | Jul 03, 2024 | Slonin Jonathan Chief Medical Officer | Sell | Pacira Biosciences, Inc. | PCRX | $28.25 | $80,117 | -2.88% |
| Jun 11, 2024 | Jun 13, 2024 | Slonin Jonathan Chief Medical Officer | Sell | Pacira Biosciences, Inc. | PCRX | $28.57 | $143,193 | -4.82% |
| Jun 06, 2023 | Jun 08, 2023 | Slonin Jonathan Chief Clinical Officer | Sell | Pacira Biosciences, Inc. | PCRX | $38.42 | $36,919 | -2.58% |
| Aug 03, 2022 | Aug 05, 2022 | Slonin Jonathan Chief Clinical Officer | Sell | Pacira Biosciences, Inc. | PCRX | $55.7 | $17,156 | -0.82% |
| Jul 05, 2022 | Jul 07, 2022 | Slonin Jonathan Chief Clinical Officer | Sell | Pacira Biosciences, Inc. | PCRX | $57.19 | $52,842 | -2.41% |
| Jun 06, 2022 | Jun 08, 2022 | Slonin Jonathan Chief Clinical Officer | Sell | Pacira Biosciences, Inc. | PCRX | $61.37 | $22,217 | -0.94% |